Vyyavlenie lits s osteoporoticheskimi perelomami i riskom ikh razvitiya


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Over the past few years, well-defined algorithm for diagnosis and treatment of osteoporosis is presented for the general practitioners. It is constantly being improved and adjusted to reflect the latest data of domestic and foreign research. Particular attention is paid not only to instrumental and laboratory methods for diagnosis, but conventional clinical examination and management of the patient.

全文:

受限制的访问

作者简介

I. Baranova

Email: baranova@ro.ru

参考

  1. Клинические рекомендации по профилактике и ведению больных остеопорозом / Под ред. проф. О.М. Лесняк. Ярославль, 2012. 24 с. (www.osteoporoz.ru).
  2. Kanis JA, on behalf of the World Health Organisation Scientific Group. Assessment of osteoporosis at the primary health care level. WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield 2007.
  3. Остеопороз / Под ред. О.М. Лесняк, Л.И. Беневоленской. 2-е изд. М., 200. 272 с.
  4. Assessment of fracture risk and its application to screening post-menopausal osteoporosis. Technical Report series 843. Geneva: World Health Organization, 1994.
  5. Adams U, Bishop N. DXA in adults and children. In: Primer on metabolic bone disease and disorders of mineral metabolism, 7 edition, www. asbmrprimer.org.
  6. Liu Z, Piao J, Pang L, Qing X, et al. The diagnostic criteria for primary osteoporosis and the incidence of osteoporosis China. J Bone Miner Metab 2002;20:181-89.
  7. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254-59.
  8. WainwrightSA, MarshallLM, EnsrudKE, CauleyJA, Black DM, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005;90:2787-93.
  9. Kanis JA, Johnell O, Oden A, et al. FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-97.
  10. Johnell O, de Laet C, Johansson H, Melton LJ, et al. Oral corticosteroids increase fracture risk independently of BMD. Osteoporos Int 2002;13 (Suppl. 1):14.
  11. van Staa T, Leufkens HGM, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002;13:777-87.
  12. Лесняк О.М., Баранова И.А., Торопцова Н.В. Клинические рекомендации «Диагностика, профилактика и лечение глюкокортикоидного остеопороза у мужчин и женщин 18 лет и старше». Ярославль, 2013. 48 с.
  13. Kanis JA. Development and use of FRAX® in osteoporosis. Osteoporos Int 2010;21(Suppl. 2):407-13.
  14. McCloskey E. FRAX® Identifying people at high risk of fracture. WHO Fracture Risk Assessment Tool, a new clinical tool for informed treatment decisions. www.iofbonehealth.org.
  15. Clinician's guide to prevention and treatment of osteoporosis. www.nofstore.org and choose «Health Professional Resources»
  16. Kanis JA, NcCloskey EV, Johansson H, at al. Case finding for the management of osteoporosis with FRAX - assessment and intervention thresholds for the UK. Osteoporos Int 2008;19:1395-408. ственных и зарубежных исследований. Основное внимание все больше уделяется не инструментальным и лабораторным методам диагностики, а общепринятому клиническому осмотру и ведению больного.
  17. Kanis JA, Johansson H, Oden A, et al. A metaanalysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004;19:893-99.
  18. van Staa TP, Leufkens HG, Abenhaim L, et al. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:933-1000.
  19. van Staa TP, Abenhaim L, Cooper C, et al. Public health impact of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol 2001;51:601-7.
  20. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C Fracture and oral corticosteroids: relationship to daily and cumulative dose. Rheumatol 2000;39:1383-89.
  21. Kanis JA, Johansson H, Oden A, McCloskey E. Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 2011;22:809-16.
  22. Leslie WD, Lix LM, Johansson H, Oden A, et al. Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int 2011;22:839-47.
  23. Baim S, Binkley N, Bilezikian JP, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 2008;11:75-91.
  24. Ferrari S, Bianchi ML, Eisman JA, et al. Osteoporosis in young adults: pathophysiology, diagnosis and management. Osteoporos Int 2012;23(12):2735-48.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2013
##common.cookie##